[1] 张欠欠,罗传玉,陈嘉琪,等.白念珠菌感染现状及抗真菌药物研究进展[J].中国真菌学杂志,2021,16(5):356-360. [2] 张浩,刘伟.致病性念珠菌对常见抗真菌药物的耐药性研究进展[J].菌物学报,2020,39(11):2109-2119. [3] Pourhajibagher M, Chiniforush N, Raoofian R, et al. Effects of sub-lethal doses of photo-activated disinfection against Porphyromonas gingivalis for pharmaceutical treatment of periodontal-endodontic lesions [J]. Photodiagnosis Photodyn Ther, 2016, 16: 50-53. [4] Abdel Hafiz Abdel Rahim AS, Abdelgawad F, Abd Alsamed AM, et al. Case report: Photo-activated oral disinfection in regenerative endodontics [J]. F1000Res, 2019, 8 : 1519. [5] 任建,李淑娟,李涛,等.根管光活化消毒技术对根管内优势致病菌的杀灭效果[J].川北医学院学报,2021,36(10):1298-1301. [6] Carmello JC, Dovigo LN, Mima EG, et al. In vivo evaluation of photodynamic inactivation using Photodithazine against Candida albicans [J]. Photochem Photobiol Sci, 2015, 14(7): 1319-1328. [7] Carmello JC, Alves F, Basso FG, et al. Treatment of oral candidiasis using photodithazine-mediated photodynamic therapy in vivo [J]. PLoS One, 2016,11(6) :e0156947. [8] Lin J, Bi LJ, Zhang ZG, et al. Toluidine blue-mediated photodynamic therapy of oral wound infections in rats [J]. Lasers Med Sci, 2010,25(2) :233-238. [9] Takakura N, Sato Y, Ishibashi H, et al. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush [J]. Microbiol Immunol, 2003, 47(5): 321-326. [10] 李成蹊,郑林霞,左露露,等.白念珠菌口腔黏膜感染小鼠模型的建立及评估 [J].口腔医学,2018,38(5): 394-398. [11] Takakura N, Sato Y, Ishibashi H, et al. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush [J]. Microbiol Immunol, 2003, 47(5):321-326. [12] 赵楠,吴桐,王娟,等.西吡氯铵含片治疗口腔念珠菌病临床疗效观察[J].中华口腔医学研究杂志(电子版),2018,12(3):158-163. [13] Lee JE, Lee JM, Lee Y, et al. The antiplaque and bleeding control effects of a cetylpyridinium chloride and tranexamic acid mouth rinse in patients with gingivitis [J]. J Periodontal Implant Sci, 2017, 47(3): 134-142. [14] 张利霞,张晶晶.764株临床分离酵母样真菌的分布类型及耐药性分析[J].中国现代药物应用,2012,6(10):75-77. [15] Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole [J]. Antimicrob Agents Chemother, 1995, 39(1):1-8. [16] 王艺,李红宾,李玉叶,等.综合医院住院患者口腔念珠菌分离株对抗真菌药物的敏感性研究[J].皮肤病与性病,2020,42(2):167-169. [17] Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance [J]. J Bacteriol, 2001,183(18): 5385-5394. [18] Lopes CM, Paula PA, José RL, et al. Biofilm formation by Candida albicans is inhibited by photodynamic antimicrobial chemotherapy (PACT), using chlorin e6: increase in both ROS production and membrane permeability [J]. Lasers Med Sci, 2018, 33(3):647-653. [19] Hu X, Huang YY, Wang Y, et al. Antimicrobial photodynamic therapy to control clinically relevant biofilm infections [J]. Front Microbiol, 2018, 9: 1299. [20] Paula PA, Bueno RI, Lopes CM, et al. Photodynamic Antimicrobial Chemotherapy (PACT), using Toluidine blue O inhibits the viability of biofilm produced by Candida albicans at different stages of development [J]. Photodiagnosis Photodyn Ther, 2018, 21:182-189. |